Drug Type Gene therapy |
Synonyms LGMD2B therapy(Atamyo Therapeutics) |
Target |
Action stimulants |
Mechanism DYSF gene stimulants(Dysferlin gene stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Limb-Girdle Muscular Dystrophy, Type 2B | Preclinical | France | 09 Aug 2022 |





